
Andreas Rück
@andreasrck2
Interventional Cardiologist at Karolinska, Stockholm, Head of Mitral/Tricuspid program.
ID: 1131195034391465984
22-05-2019 13:48:07
594 Tweet
1,1K Followers
325 Following


Good mid-term durability of the Acurate Neo #TAVR. Low rate (1,1% at mean 39 months FUP) of severe Hemodynamic Valve Deterioration. 433 core-lab analysed echos from Karolinska Univ.sjuk. BostonSci Cardiology EuroIntervention


Acurate Prime #tavr CE marked. Great news. Soon to be rolled out at Karolinska and other European Centers. Will be interesting to see improved results with the added radial strength, a large study is planned here. BostonSci Cardiology


4 x ACURATE Prime #tavi at Karolinska Univ.sjuk today. 2x Bicuspid, 1x hostile access, 1x heavily calcified leaflets. Good result in all. Updated device with super-fast final release and ⬆️ radial strength. BostonSci Cardiology TAVR Bot Simultaneous start at 5 EU sites today

Just published on the occasion of #PCRLV: The Neo2 BAV registry evaluated the safety and efficacy of ACURATE neo2 in patients with BAV stenosis. Chiara De Biase asked first author Andreas Rück to share insights on the study⬇️

181 bicuspid #TAVR with Acurate neo2: only 4% moderate PVL, mean gradient 6 mmHg, new pacemaker 6%. Read the paper at EuroIntervention. Darren Mylotte Magnus settergren

